Ondra Health vs. Gimme Care: Compounded GLP-1 Compared (2026)
Ondra Health and Gimme Care are both flat-rate compounded GLP-1 telehealth platforms with no membership fees. The core difference: Ondra names all five pharmacy partners publicly. Gimme Care does not. Here is the full pricing, pharmacy transparency, and clinical model comparison.
Key takeaways
Ondra semaglutide is $11/month cheaper than Gimme Care ($149 vs. $160 monthly) and $17/month cheaper on a quarterly basis.
Gimme Care's tirzepatide monthly rate ($199) is lower than Ondra's ($219), but Gimme Care uses a 1.5 mg starting dose versus the standard 2.5 mg starting dose.
Ondra names all five pharmacy partners publicly with license type, state restrictions, and formulation details. Gimme Care does not disclose which pharmacies fill its prescriptions.
Both platforms are LegitScript certified with asynchronous intake and provider review.
What both platforms have in common
Both Ondra Health and Gimme Care offer compounded semaglutide and tirzepatide through licensed telehealth providers with asynchronous intake, flat-rate pricing that does not increase with dose escalation, no mandatory membership fee, and free shipping. Both are LegitScript certified. For a patient evaluating this category, both are legitimate options. The important caveat that applies to both: compounded medications are not FDA-approved and are not therapeutically equivalent to brand-name products like Wegovy® or Zepbound®.
Pricing comparison
Compounded semaglutide — monthly cost (June 2026)
Ondra Health: $149/month on a monthly plan · $113/month on a quarterly plan ($339 billed every 3 months)
Gimme Care: $160/month on a monthly plan · $130/month on a quarterly plan ($390 billed every 3 months)
Ondra is cheaper at every plan length. On a quarterly basis, Ondra saves $17 per month, or $204 per year, compared with Gimme Care.
Compounded tirzepatide — monthly cost (June 2026)
Ondra Health: $219/month on a monthly plan · $183/month on a quarterly plan ($549 billed every 3 months)
Gimme Care: $199/month on a monthly plan · $163/month on a quarterly plan ($489 billed every 3 months)
Tirzepatide monthly billing is $20 cheaper through Gimme Care. On quarterly billing, Gimme Care is also approximately $20 per month cheaper. However, see the dosing note below regarding Gimme Care's reported 1.5 mg tirzepatide starting dose.
Gimme Care's non-standard tirzepatide starting dose
Starting dose: 1.5 mg vs. 2.5 mg
Gimme Care's reported starting dose for compounded tirzepatide is 1.5 mg, which is lower than the 2.5 mg starting dose used in the SURMOUNT-1 clinical trial and by most other GLP-1 providers, including Ondra Health. When comparing monthly pricing between platforms, it is important to consider the prescribed dose you are receiving for that price. A lower starting dose may mean a lower supply cost to the pharmacy, but dosing is a clinical decision that should be discussed with a licensed provider.
Pharmacy transparency
Because compounded medications are not FDA-approved, the identity and regulatory standing of the compounding pharmacy are important factors for patients to consider. Knowing which pharmacy fills your prescription allows you to review its licensing, accreditation, and formulation information.
Ondra Health
Ondra publicly names all five active pharmacy partners — Hallandale Pharmacy, Boudreaux's New Drug Store, Vials RX, Apothecary Pharma, and White Label/Nova Pharmacy — along with their license types, state restrictions, and formulation details. This information is available at ondra.health/pharmacy-partners before you begin your intake.
Gimme Care
Gimme Care does not publicly disclose which compounding pharmacies fill its prescriptions as of June 2026. The company states that it uses U.S.-licensed pharmacies but does not name them publicly. Patients should request the pharmacy's name and formulation details before beginning treatment if that information is important to their decision.
Clinical model
Ondra Health
Asynchronous telehealth. Intake is reviewed by licensed providers at Wasef Health, PC, an independent medical practice. A video call is not required in most states, although certain states may require a phone or video consultation. Ongoing provider messaging is available for dose adjustments and clinical questions.
Gimme Care
Asynchronous telehealth with provider review and ongoing messaging. Its clinical model is similar in structure to Ondra's. Patients should review Gimme Care's current provider network, consultation requirements, and expected review times directly through the platform.
Who each platform fits better
Ondra may be the better fit if…
You want the lower published semaglutide price. You want to know your pharmacy by name before beginning treatment. You value a platform that publicly discloses its providers, pharmacies, formulations, and pricing.
Gimme Care may suit you if…
You want the lower published tirzepatide rate and are comfortable requesting pharmacy information directly. You value unlimited provider messaging as a featured benefit. You have discussed the reported 1.5 mg starting dose with your provider and are comfortable with the prescribed treatment plan.
Frequently asked questions
Is Gimme Care cheaper than Ondra Health?
For semaglutide, no. Ondra is cheaper at every published plan length: $149 vs. $160 per month on monthly billing and $113 vs. $130 per month on quarterly billing. For tirzepatide, Gimme Care's published monthly and quarterly rates are approximately $20 per month lower. Prices are based on publicly available information from June 2026 and should be verified directly with both platforms before enrolling.
Does Gimme Care name its pharmacies?
As of June 2026, Gimme Care does not publicly disclose which compounding pharmacies fill its prescriptions. Ondra Health publicly names its five pharmacy partners and provides information about license type, state availability, and formulations.
What is Gimme Care's tirzepatide starting dose?
Gimme Care's reported starting dose for tirzepatide is 1.5 mg, which is lower than the 2.5 mg starting dose used in clinical trials and by many providers, including Ondra. Dosing decisions should be discussed with a licensed provider because the appropriate dose depends on the patient's individual clinical profile.
Does Ondra Health require a commitment?
No. Ondra Health has no cancellation fee or long-term commitment. Monthly billing is available at $149 per month for semaglutide or $219 per month for tirzepatide. Quarterly billing requires payment for the 3-month supply upfront, but future renewals can be canceled before the next scheduled billing date.
† This article is for informational purposes only. Pricing and service information for Gimme Care is based on publicly available information as of June 2026 and is subject to change. Verify current pricing, dosing, pharmacy information, and program terms directly with Gimme Care before making a decision. Compounded semaglutide and tirzepatide are not FDA-approved and are not therapeutically equivalent to FDA-approved brand-name medications. Ondra Health is not affiliated with Gimme Care.